# 5-LOXIN (Boswellia, 30% AKBA)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/5-loxin-boswellia-30-akba
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-18
**Evidence Score:** 8 / 10
**Category:** Other
**Also Known As:** Boswellia serrata, Indian frankincense, Salai guggul, Shallaki, Indian olibanum, AKBA extract, Boswellic acid concentrate

## Overview

5-LOXIN is a standardized Boswellia serrata extract containing 30% AKBA (3-O-acetyl-11-keto-β-boswellic acid) that inhibits 5-lipoxygenase enzyme activity. This selective inhibition reduces [inflammatory](/ingredients/condition/inflammation) mediators like leukotrienes, providing targeted joint pain relief and cartilage protection.

## Health Benefits

- 5-LOXIN provides potent [anti-inflammatory](/ingredients/condition/inflammation) effects by inhibiting the 5-lipoxygenase enzyme, reducing joint pain and swelling. This can improve mobility and quality of life. - It supports joint health by maintaining cartilage integrity and reducing degradation. Healthy cartilage is crucial for pain-free movement. - 5-LOXIN enhances respiratory health by reducing inflammation in the airways. This can alleviate symptoms of asthma and improve breathing. - It supports [digestive health](/ingredients/condition/gut-health) by reducing inflammation in the gut lining. A healthy gut lining can prevent conditions like IBS. - 5-LOXIN promotes [cardiovascular health](/ingredients/condition/heart-health) by improving endothelial function. Enhanced endothelial function can lower blood pressure and reduce heart disease risk. - It aids in skin health by reducing inflammation and promoting [collagen production](/ingredients/condition/skin-health). This can result in firmer, more youthful skin. - 5-LOXIN supports [mental health](/ingredients/condition/mood) by reducing neuroinflammation. Lower neuroinflammation can improve [cognitive function](/ingredients/condition/cognitive) and reduce the risk of neurodegenerative diseases.

## Mechanism of Action

5-LOXIN's primary bioactive compound AKBA selectively inhibits 5-lipoxygenase (5-LOX) enzyme, blocking the conversion of arachidonic acid to [inflammatory](/ingredients/condition/inflammation) leukotrienes. This inhibition reduces pro-inflammatory mediators LTB4 and 5-HETE while preserving beneficial cyclooxygenase pathways. The extract also modulates NF-κB signaling and inhibits matrix metalloproteinases that degrade cartilage collagen.

## Clinical Summary

Human trials with 5-LOXIN have shown significant improvements in joint function and pain reduction. A 90-day study with 60 osteoarthritis patients using 100mg daily demonstrated 65% improvement in pain scores and 61% improvement in joint function compared to placebo. Additional studies indicate onset of benefits within 7 days of supplementation. However, most clinical data comes from small-scale trials requiring larger confirmatory studies.

## Nutritional Profile

5-LOXIN is a standardized Boswellia serrata extract concentrated to 30% acetyl-11-keto-β-boswellic acid (AKBA), its most pharmacologically active boswellic acid. Typical clinical doses range from 100–250 mg/day, delivering approximately 30–75 mg of AKBA per serving. Additional boswellic acids present include β-boswellic acid, 11-keto-β-boswellic acid (KBA), and α-boswellic acid at varying concentrations. AKBA demonstrates selective, non-redox inhibition of 5-lipoxygenase (5-LOX) with an IC50 of approximately 1.5 µM. Bioavailability of boswellic acids is notably enhanced when taken with a high-fat meal (up to 2-fold increase in Cmax), as these are lipophilic triterpenic acids. The extract contains negligible macronutrients (protein, carbohydrates, fat) in functional doses, and does not contribute meaningfully to vitamin or mineral intake. Phospholipid-complexed formulations (e.g., phytosome delivery) can further enhance AKBA absorption by improving gut wall permeability.

## Dosage & Preparation

Typical dosages range from 100 mg to 250 mg per day. Consult a healthcare provider before use.

## Safety & Drug Interactions

5-LOXIN is generally well-tolerated with mild gastrointestinal upset reported in some users. It may enhance the effects of [anti-inflammatory](/ingredients/condition/inflammation) medications and blood thinners due to its anti-platelet properties. Individuals with bleeding disorders or those taking anticoagulant medications should consult healthcare providers before use. Safety during pregnancy and lactation has not been established, so use should be avoided during these periods.

## Scientific Research

Clinical studies have demonstrated that 5-LOXIN effectively reduces [inflammation](/ingredients/condition/inflammation) and joint pain. RCTs and meta-analyses support its use in improving joint function and reducing symptoms of osteoarthritis.

## Historical & Cultural Context

Boswellia, also known as frankincense, has been used in traditional Ayurvedic medicine for its [anti-inflammatory](/ingredients/condition/inflammation) properties. It holds cultural and religious significance in various ancient civilizations.

## Synergistic Combinations

5-LOXIN pairs powerfully with Curcumin (standardized to 95% curcuminoids), as curcumin inhibits COX-2 and NF-κB pathways while AKBA targets 5-LOX, creating a dual-pathway [anti-inflammatory](/ingredients/condition/inflammation) blockade that reduces both prostaglandin and leukotriene synthesis simultaneously — this combination has shown additive reductions in joint pain markers in clinical studies. UC-II (undenatured type II collagen) complements 5-LOXIN's cartilage-protective effects by providing oral tolerance mechanisms to reduce autoimmune cartilage degradation, while AKBA specifically inhibits matrix metalloproteinase (MMP) activity to preserve the collagen matrix UC-II supports. Piperine (BioPerine, 5–10 mg) is a critical addition as a bioavailability enhancer — by inhibiting CYP3A4 and P-glycoprotein efflux, it increases AKBA and co-administered curcuminoid plasma concentrations by up to 20–30%; additionally, Omega-3 fatty acids (EPA/DHA) provide complementary 5-LOX substrate competition and downstream anti-inflammatory eicosanoid production (resolvins, protectins) that extend AKBA's leukotriene-suppressing effects.

## Frequently Asked Questions

### Does 5-LOXIN help with osteoarthritis symptoms?

Yes. Clinical randomized controlled trials have demonstrated that 5-LOXIN, standardized to 30% AKBA, significantly reduces osteoarthritis pain and improves joint function. AKBA selectively inhibits the 5-lipoxygenase enzyme, blocking leukotriene production and reducing inflammatory mediators like LTB4. It also inhibits matrix metalloproteinases that break down cartilage collagen, addressing both pain symptoms and underlying joint degradation. Studies show measurable improvements in pain scores and mobility within weeks of consistent use.

### Can 5-LOXIN help with asthma or respiratory inflammation?

5-LOXIN may support respiratory health by reducing airway inflammation through 5-LOX inhibition. Leukotrienes, particularly LTB4, are key mediators of bronchoconstriction and airway inflammation in asthma. By blocking 5-lipoxygenase, AKBA reduces leukotriene synthesis in the airways, which may alleviate asthma symptoms and improve breathing. While joint health research is more extensive, the same anti-inflammatory mechanism that targets joints also applies to respiratory tissues. Consult a healthcare provider before using it as a respiratory intervention.

### What are the side effects of 5-LOXIN?

5-LOXIN is generally well tolerated in clinical studies at recommended doses of 100–250 mg per day. Because it inhibits 5-lipoxygenase rather than cyclooxygenase pathways, it avoids the gastrointestinal side effects commonly associated with NSAIDs. Mild digestive discomfort has been occasionally reported. It does not appear to cause stomach ulcers or liver toxicity at standard doses. However, individuals with Boswellia allergies, those who are pregnant, or those on anti-inflammatory medications should consult a healthcare provider before use.

### Is 5-LOXIN safe to take with NSAIDs or ibuprofen?

5-LOXIN works via a distinct mechanism — inhibiting 5-lipoxygenase — compared to NSAIDs like ibuprofen, which inhibit cyclooxygenase (COX) enzymes. This complementary action means they may theoretically be used together, potentially allowing for reduced NSAID doses. However, combining anti-inflammatory agents can have additive effects on inflammatory pathways. There is limited direct clinical data on this combination. Always consult a healthcare provider before combining 5-LOXIN with NSAIDs or any prescription anti-inflammatory medications to avoid unintended interactions.

### Can 5-LOXIN protect cartilage from further degradation?

Yes. Beyond pain relief, 5-LOXIN's AKBA compound inhibits matrix metalloproteinases (MMPs), enzymes responsible for breaking down collagen and cartilage tissue. This provides a structural protective effect on joints, not just symptomatic relief. By also modulating NF-κB signaling — a master regulator of inflammatory gene expression — 5-LOXIN helps reduce the inflammatory environment that accelerates cartilage destruction. This dual action makes it particularly relevant for individuals seeking to slow the progression of osteoarthritis rather than simply manage pain.

### Does 5-LOXIN have any benefits for gut health or IBS?

5-LOXIN may support digestive health by reducing inflammation in the gut lining through 5-LOX inhibition. Leukotrienes contribute to intestinal inflammation seen in conditions like irritable bowel syndrome and inflammatory bowel disease. By blocking leukotriene production, AKBA may help reduce gut lining inflammation and associated symptoms. Standard Boswellia extracts have been studied for Crohn's disease and ulcerative colitis with promising results. However, direct clinical evidence for 5-LOXIN specifically in IBS is limited. Consult a healthcare provider for gut-related conditions.

### How does 5-LOXIN compare to turmeric or curcumin for inflammation?

5-LOXIN and curcumin both target NF-κB signaling and reduce inflammatory mediators, but they act through different primary mechanisms. 5-LOXIN specifically inhibits the 5-lipoxygenase enzyme, reducing leukotriene production — a pathway curcumin does not target as selectively. Curcumin primarily inhibits COX-2 and NF-κB. Because their mechanisms are complementary, some joint formulas combine both. 5-LOXIN has the advantage of high bioavailability as a standardized extract at relatively low doses (100–250 mg daily), whereas curcumin typically requires larger doses or enhanced delivery systems for similar efficacy.

### Can 5-LOXIN support brain health or reduce neuroinflammation?

Emerging evidence suggests 5-LOXIN may support cognitive health by reducing neuroinflammation. The 5-lipoxygenase pathway is active in brain tissue, and elevated leukotriene levels have been linked to neuroinflammatory processes associated with cognitive decline and neurodegenerative conditions. By inhibiting 5-LOX and modulating NF-κB signaling, AKBA may help lower neuroinflammatory activity. While joint health remains the best-studied application, the same systemic anti-inflammatory mechanism could benefit brain health. Robust clinical trials specifically targeting cognitive outcomes with 5-LOXIN are still needed.

### What is the optimal dosage of 5-LOXIN for joint pain?

Clinical studies typically use 100-250mg of 5-LOXIN daily, standardized to 30% AKBA. Most research shows 100mg daily provides significant joint pain relief within 7-30 days of consistent use.

### How long does it take for 5-LOXIN to work?

5-LOXIN can provide initial pain relief within 7 days, with maximum benefits typically observed after 30-90 days of consistent use. Some users report improved mobility and reduced morning stiffness within the first two weeks.

### What makes 5-LOXIN different from regular Boswellia?

5-LOXIN is standardized to contain 30% AKBA, the most potent anti-inflammatory compound in Boswellia. Regular Boswellia extracts typically contain only 2-10% AKBA, making 5-LOXIN significantly more concentrated and effective.

### Can 5-LOXIN be taken with other joint supplements?

5-LOXIN can generally be combined with glucosamine, chondroitin, and MSM safely. However, combining with other anti-inflammatory supplements like curcumin or fish oil may increase bleeding risk and should be monitored by a healthcare provider.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*